ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2019
Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.
Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04530240 (Impact of National MELD ≥ 30 Priority Allocation System on Dropout and Post-Transplant Survival Rates in Italy), which is not on this map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of National MELD ≥ 30 Priority Allocation System on Dropout and Post-Transplant Survival Rates in Italy: A Retrospective Competing-Risk Analysis
Who cites it
24 citing papers in PubMed, 78 citations in OpenAlex.
- Enhancing short-term predictions of mortality risk for liver transplant candidates through random survival forests.Scientific reports · 2026Article
- Access to the Liver Transplant Waitlist in Patients With HCC: A National EHR Study of Center Level Variation among 11 422 Referrals.Clinical transplantation · 2026Article
- The UK National Appeals Panel Safely Extends Access to Liver Transplantation for Candidates Beyond Standard Listing Criteria.Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
- Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis.Liver cancer · 2024Article
- The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.Hepatology communications · 2024Article
- Radiological-histopathological discordance in patients transplanted for HCC and its impact on post-transplant outcomes.Cancer medicine · 2023Article
- CON: Is liver organ allocation with MMaT-3 appropriate prioritization for patients with liver cancer?Clinical liver disease · 2023Article
- Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience.Frontiers in pediatrics · 2023Article
- Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?Transplant international : official journal of the European Society for Organ Transplantation · 2021Article
- MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021Article
- Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression.Annals of translational medicine · 2021Article
- Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma.Journal of hepatocellular carcinoma · 2021Article
- Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.The American journal of gastroenterology · 2020Article
- T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices.Transplantation direct · 2020Article
- How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020Article
- Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology.Hepatic oncology · 2020Review
- Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2020Article
- Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma.Transplantation · 2020Article
- LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis.Cancer management and research · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 1 institution in 1 country.
Funding
Abstract
Historically, exception points for hepatocellular carcinoma (HCC) led to higher transplant rates and lower waitlist mortality for HCC candidates compared to non-HCC candidates. As of October 2015, HCC candidates must wait 6 months after initial application to obtain exception points; the impact of this policy remains unstudied. Using 2013-2017 SRTR data, we identified 39 350 adult, first-time, active waitlist candidates and compared deceased donor liver transplant (DDLT) rates and waitlist mortality/dropout for HCC versus non-HCC candidates before (October 8, 2013-October 7, 2015, prepolicy) and after (October 8, 2015-October 7, 2017, postpolicy) the policy change using Cox and competing risks regression, respectively. Compared to non-HCC candidates with the same calculated MELD, HCC candidates had a 3.6-fold higher rate of DDLT prepolicy (aHR =
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.